The Billion Dollar Molecule by Barry Werth
One Company's Quest for the Perfect Drug

No critic rating

Waiting for minimum critic reviews

See 2 Critic Reviews



An inside account of the start-up of a biotechnology company describes its struggle to bring a lifesaving drug to market, discussing the risky financing and profiling the venture capitalists involved. 30,000 first printing.

About Barry Werth

See more books from this Author
Barry Werth brought the story of Newton Arvin and the "Smith College Homosexual Scandal of 1960" to national attention for the first time in almost forty years in The New Yorker. Werth is the author of The Billion-Dollar Molecule and Damages. In addition to The New Yorker, his articles have appeared in the New York Times Magazine, GQ, and Outside. He lives in Northampton, Massachusetts.
Published February 16, 1994 by Simon & Schuster. 448 pages
Genres: Business & Economics, Education & Reference, Nature & Wildlife, Professional & Technical, Science & Math, Health, Fitness & Dieting. Non-fiction

Unrated Critic Reviews for The Billion Dollar Molecule

Kirkus Reviews

See more reviews from this publication

A you-are-there account of the turbulent early days of Vertex, a high-tech, high-risk biotechnology firm.

May 20 2010 | Read Full Review of The Billion Dollar Molecule: ...

Publishers Weekly

See more reviews from this publication

Freelance writer Werth has taken two complex industries--biotechnology and high finance--and woven them into an intriguing story. The subject of his book is Vertex, a start-up firm headquartered in Ca

Jan 31 1994 | Read Full Review of The Billion Dollar Molecule: ...

Reader Rating for The Billion Dollar Molecule

An aggregated and normalized score based on 27 user ratings from iDreamBooks & iTunes

Rate this book!

Add Review